QA: Decoy Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001615219_2019_Decoy_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001615219, Decoy Therapeutics Inc

  xvar xval
0 AssetsCurrent 10,315,166
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 74,460
3 remainder_Assets 0
4 LiabilitiesCurrent 1,106,870
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 430,750
8 SellingGeneralAndAdministrativeExpense 10,573,321
9 ResearchAndDevelopmentExpense 11,908,294
10 remainder_Expenses 0
11 remainder_Revenues 838,142
12 remainder_NetIncome 152,006
13 remainder_ComprehensiveNetIncome 1,247
  yvar yval
0 Assets 10,389,626
1 Liabilities 1,106,870
2 Expenses 22,912,365
3 Revenues 838,142
4 StockholdersEquity 9,282,756
5 NetIncome -21,922,217
6 ComprehensiveNetIncome -21,921,594
7 BaseVar 17,700,128
8 EconomicCapitalRatiobeforeLimitedLiability -0.293
9 EconomicCapitalRatio 1.40

Edgar->Model Mapping

Feature Distribution

Change over Time